Scale parameters are used to combine two or more models in different scales into one integrative model. One of the crucial issues in the research eld of biosimulation in hemodynamics is how to determine the scale parameters in comprehensive hemodynamic models comprising a cardiac cellular contraction model and a circulation model. In this report, we propose a method for determining the scale parameters using mathematical equations derived from the shape of the left ventricle (LV), which is assumed to be a hemisphere. In this method, we derived ve equations with seven unknown scale parameters. By using measured values of hemodynamic parameters such as the end-systolic and end-diastolic pressures and LV volume, we successfully determined seven scale parameters to reproduce pathological data of progressive hypertension in Dahl salt-sensitive rats. From the results, we found that accompanying the progression of hypertension, the active contraction force at end-diastole rst increase by 54%, followed by 93% increase of the passive elastic force. We also successfully reproduced normal human physiological hemodynamics.
Introduction
A large volume of research has investigated elements of the circulation system, including cardiac cells and heart pump functions, and various models have been proposed for these elements [1] [2] [3] [4] [5] [6] . Since the characteristics of these elements have been measured in detail, the accuracy of these models is quite high.
For the ventricular myocyte model, a model that can calculate cellular active contraction force is proposed by Negroni and Lascano [4] . Compared to other models [3, 7] , this model can reproduce realistic cellular force time courses both in isometric and isotonic conditions. For the circulation model, Heldt et al. [2] proposed a whole body circulation model that can reproduce accurate blood ow to each organ, however, since this model uses time-varying elastance model as left and right ventricle elements, the relation between cellular characteristics such as end-systolic active contraction force and end-diastolic active contraction force, or the relation between ventricular wall tension and cellular active contraction force cannot be evaluated.
Wang et al. [1] proposed an infantile cardiovascular hemodynamic model comprising a baroreceptor re ex model, blood vessel model, left ventricular geometry model, cardiac cellular contraction model, and cardiac cell model. This model reproduced physiological hemodynamic parameters such as the end-systolic pressure-volume relation (ESPVR), the slope of this relation E max [8] , and the end-diastolic pressure-volume relation (EDPVR) [8] [9] [10] . Since this model is composed of both organ-level and cellular-level models, several scale parameters converting cellular-level parameters to organ-level parameters are used. In this model, scale parameters are the relation between the cellular contraction model and the ventricular wall tension, cellular sarcomere length and the ventricular size, cellular slack length and the ventricular equilibrium volume, as well as cellular passive elastance and ventricular elastance.
There are also models which include cellular-level contraction model and organ-level model, such as Auckland group model [11] and UT-Heart [12] . Although these models use scale parameters, there were no explicit discussion about the scale parameters in the previous papers. We also have to point out that these scale parameters are dif cult to measure directly, and their values remain unknown. Thus, methods for determining these scale parameters are necessary for constructing realistic circulation models.
On the other hand, many hemodynamic and anatomical parameters have been measured and reported under various conditions. If the proposed models for elements of the circulation system are suf ciently accurate, we can determine the scale parameters for the circulation system.
In this research, we propose a novel calculation method to determine the unknown scale parameters in comprehensive multiscale hemodynamic models using mathematical equations derived from Laplace s left ventricular hemispherical model [13] . In this method, ve equations were derived and seven scale parameters remained unde ned. By combining those equations with experimental hemodynamic parameters obtained at both cellular and organ levels and giving two xed values as known parameters, we successfully determined seven unknown scale parameters. This method was applied to two hemodynamic models; 1) progressive hypertension in the Dahl salt-sensitive rat model, and 2) a normal physiological adult human model. The applicability of the method to the two hemodynamic models and its interpretation will be discussed.
Construction of a left ventricle model
To determine the values of the unknown scale parameters, we used several equations to relate several organ-level and cellular-level physiological measured data. As measured physiological data, we used left ventricular pressure (P lv (t)), left ventricular volume (V lv (t)), left ventricular wall thickness (h lv (t)), left ventricular radius (R lv (t)), left ventricular wall tension (F(t)), cellular active contraction force (F b (t)), passive elastic force (F p (t)), cellular half sarcomere length (L(t)). As model equations, we used the relation between 1) P lv (t), R lv (t), h lv (t) and F(t), 2) R lv (t) and V lv (t), 3) L(t) and R lv (t), 4) F(t), F b (t) and F p (t), 5) h lv (t) and F b (t), and 6) F p (t) and L(t). Since not all the above data are available through the cardiac cycle, we de ned the time of end-systole as t ES , and the time of end-diastole as t ED to specify the time.
Since the Laplace s law well represents the relation between P lv (t), h lv (t), F(t), and R lv (t) [14] , we used it to represent these relations as follows [13] .
We also needed a model equation describing the relation between the left ventricular volume and left ventricular radius. We used the following reported data to de ne mathematical equations for this relation.
Corsi et al. [15] measured the time course of human left ventricular volume, and Sutton et al. [16] measured the time course of human left ventricular internal radius. By combining these data, we obtained a non-linear relationship between the left ventricular volume and internal radius. Since the resolution of these data are not high enough, we used the time course of the canine left ventricular volume reported by Rodriguez et al. [17] and the time course of the canine left ventricular internal diameter reported by Sabbah et al. [18] to draw the non-linear relation between left ventricular volume and internal radius. When we linearly scaled the end-systolic volume, end-diastolic volume, end-systolic internal diameter and end-diastolic internal diameter from the canine data to the human data as shown in Fig. 1 , we obtained a curve with basic characteristics close to the human data. Thus, we used the canine plot scaled to the human data to construct mathematical equation which represents this relation.
Another model equation we needed was an equation to describe the relation between left ventricular radius and left ventricular sarcomere length. We used the following reported data to de ne mathematical equations for this relation.
Rodriguez et al. [17] also measured the time course of the canine sarcomere length. By combining this data with the measured canine time course of internal diameter reported by Sabbah et al. [18] , we obtained a non-linear relationship between left ventricular volume and sarcomere length. Since the in vivo or in situ human sarcomere length has not been reported to our knowledge, we linearly scaled the canine end-systolic left ventricular radius and end-diastolic radius to human data, which is shown in Fig. 2 .
For the relation between F p and F b , usually their summation is used as F. If we consider using F as the left ventricular wall tension in Laplace s law, since F p is usually measured with whole left ventricle, F p can be used as a component of F. However, since F b is usually measured in single cell or small tissue, F b may require scaling factor to relate to F, because the structure of the left ventricular wall is not a single ber of ventricular myocytes.
From the above explanations, we used the relation between left ventricular volume and radius, the relation between left ventricular radius and sarcomere length, and the relation among left ventricular wall tension, cellular active contraction force and passive elastic force as follows.
Note that K α and K β are model parameters that de ne the non-linear characteristics between V lv and R lv . V γ is V lv -intercept of the relationship between V lv and R lv . K L is proportional constant of the relationship between L and R lv . L b is L-intercept of the relationship between L and R lv . K S is the ratio of cardiac cell to ventricular wall tension.
Next, we considered the wall thickness. Yun et al. [19] measured the time course of the left ventricular volume, twist angle, and wall thickness, and reported that both the volume and twist angle were related to wall thickness. Moreover, wall thickness is commonly known to become maximal at the end-systolic point and minimal at the end-diastolic point. However, wall thickness is not always proportional to left ventricular volume [15, 16] , and the quantitative mechanism for wall thickness is still unknown. On the other hand, wall thickness is known to change at isovolumic relaxation phase [20] , where the cellular active contraction force decreases. Thus, we assumed that F b (t) is linearly related to [21, 22] . Since the model equation is based on this model, we used the non-linear model proposed by Shim et al. [5] to calculate the passive elastic force. The model is based on organ-level measurements, represented as follows.
Where L 0 is the half sarcomere slack length, and D, K PE , and K PL are the scale parameters for the heart wall and cardiac cell passive elasticity.
The volume-axis intercept of EDPVR is called the equilibrium volume (V eq ), which gives the unstressed volume at end-diastole. L 0 is the half sarcomere length when left ventricular volume becomes V eq , since the active and the passive forces become 0 in unstressed condition [23] [24] [25] [26] .
A method to determine scale parameters in hemodynamic models
We have de ned six scale parameters
. In section 3.1, we de ne one parameter K fb , and present ve equations to represent the relationships among them.
3.1
Five equations for the determination of seven scale parameters Relationships among scale parameters with respect to the measured hemodynamic parameters were analyzed. We used one end-systolic point (ESP) and three end-diastolic points (EDP, EDP2, EDP3). We also introduced a mechanical constraint: the passive elastic force equation (Eq. 6) is smooth at L 0 .
Using the ratio between end-systolic to end-diastolic cellular active contraction force K fb , F b (t ES ) can be described as follows.
Although the active contraction force at end-diastole may vary according to V lv (t ED ), we assumed that
, since their differences are small compared to the passive elastic force at end-diastole. Thus the relationships among F(t), F b (t) and F p (t) at ESP, EDP, EDP2 and EDP3 can be derived from the model equations Eq. (4), Eq. (6) and Eq. (7), as follows.
Note that the above equations include seven unknown scale parameters.
By introducing smoothness to the passive elastic force equation (Eq. 6), we obtain the following equation.
3.2 Utilization of experimental hemodynamic parameters within the method Since we have ve equations [(8) , (9), (10), (11), (12)] with seven unknown scale parameters
xing two scale parameters, we obtain ve independent scale parameter values, if the given conditions have solution.
We selected seven unknown scale parameters in the model that are dif cult to measure directly from animal experiments or clinical tests. For the other parameters in the model, values can be determined from measured data.
Here we assumed that P lv (t) and V lv (t) at ESP, EDP, EDP2 and EDP3 can be obtained directly from measured data. R lv (t) and L(t) at these points were calculated from the model equations (2) and (3). h lv (t) is known to be inversely proportional to V lv (t) at end-diastole [27] . However, here we assumed that the differences in wall thickness at EDP, EDP2 and EDP3 are small (
). The effect of this assumption is discussed in Section 6.
An application of the method to progressive hypertension in Dahl salt-sensitive rats
We used the calculation method proposed in the previous section to determine the unknown scale parameters for estimating changes in model parameter values with progression of hypertension in rat experimental data. Moreover, changes in the cellular contraction force and passive elasticity were analyzed in hypertension. We used Dahl rat hypertension hemodynamic data reported by Klotz et al. [28] .
Experimental hemodynamic parameters utilized in a hypertensive rat model
We used measured hypertensive hemodynamic data from Dahl salt-sensitive rats as reported by Klotz et al. [28] . In that report, a low-salt diet (LS, 0.3% NaCl) was fed to rats until 7 weeks old. Rats were then divided into 8 groups according to experimental conditions: rats given LS for 8 weeks (w8LS), 12 weeks (w12LS), 16 weeks (w16LS), or 20 weeks (w20LS); or high-salt diet (HS, 8% NaCl) for 8 weeks (w8HS), 12 weeks (w12HS), 16 weeks (w16HS), or 20 weeks (w20HS). Left ventricular hemodynamic parameters were measured under both conditions. Since these experimental data were obtained from rats, we introduced some assumptions to convert our model to t rat data. Vahl et al. [29] reported that the half sarcomere length which gives peak active contraction force of human heart is 1.1 μm, which is in the normal range reported in rats and cats [30, 31] . The half sarcomere length of the beating dog heart is reported to be around 0.85-1.2 μm [17] which is close to the range used in our model. For the active contraction force property, a report that compared the force frequency relation of human, dog and rat cardiac myocytes [32] concluded that their basic characteristics are very close. Thus we assumed that cellular-level parameters are similar in dog and human data. On the other hand, we could not nd the relation among V lv (t), R lv (t) and L for rats. However, since the difference in heart structure between rat and human may be small, we assumed that the organ-level data of human and rat is linearly related.
Advanced Biomedical Engineering. Vol. 5, 2016. (34) First, the relationship between R lv (t) and V lv (t) was the same as in dogs, but the volume was linearly reduced to t the rat volume, resulting in K α = 2.73, K β = 2.03, and V γ = 0.102 mL. We assumed that the working half sarcomere length L = 0.95-1.10 μm is the same for rats, and using the w8LS left ventricular radius reported in the paper by Klotz et al. [28] , we obtained K L = 0.634 μm/cm and L b = 0.824 μm.
Klotz et al. only measured one point for the end-diastole, but measured the EDPVR curve using an isolated heart. Although our calculation method assumes three measured points at the end-diastole, we can change the calculation method to use one end-diastole point and two points on the isolated EDPVR. Here, we used two points on the isolated EDPVR: EDP2 and EDP3 . The data set used in this section is summarized in Table S1 in the supplemental material.
Since the wall thickness at EDP and ESP was not reported by Klotz et al., we used the data reported by Qu et al. [33] . In that report, Dahl salt-resistant rats and salt-sensitive rats at 6 weeks of age were given a high-salt diet (8% NaCl) until 12 weeks and the change in wall thickness during this period was measured. Since Klotz et al. measured data until 20 weeks, we assumed that posterior wall thickness does not change from 12 weeks to 20 weeks, and wall thickness of salt-resistant rats on high salt diet resembles that of salt-sensitive rats on low salt diet. In Klotz s report [28] , an isolated heart with no active contraction force was used to measure EDPVR. Thus, we used the following equations instead of Eq. (10) and Eq. (11) .
Changes in scale parameters
In this analysis, information on cellular function was not available, therefore K S and F b (t ED ) were combined as one parameter (K S ·F b (t ED )). In this case, the number of unknown scale parameters becomes six, with values needed to be calculated from ve equations Eq. (8), Eq. (9), Eq. (12), Eq. (13) and Eq. (14).
Since we have to provide one unknown scale parameter value to calculate the other scale parameters, we provided L 0 within the physiological range, and obtained ranges for the other parameters. First, we selected L 0 = 1.034 as the baseline w8LS value of L 0 . We then obtained V eq for all conditions, and calculated the ratio of the corresponding half sarcomere lengths among them. Finally, we obtained L 0 for each condition, as shown in Table 1 .
Time courses for K S ·F b (t ED ) and F p (t ED ) are shown in Fig. 3 . K S ·F b (t ED ) was almost the same between w8 and w20 under LS conditions. On the other hand, the values increased by 54% from w12 to w16 under HS conditions. In terms of cellular conditions, the value of K fb was almost the same from w8 to w20 under LS conditions, but this ratio increased under HS conditions. Since increases in K S ·F b (t ED ) and K fb imply an increased end-systolic contraction force K S ·F b (t ES ), the work performed by each cardiac cell is considered to be increased. Also, due to the increase in K S ·F b (t ED ), P lv (t ED ) among the hemodynamic parameters (Table  S1) increased. In fact, the analysis showed increase in end-diastolic cellular contraction force, and that seems to be the main reason why the end-diastolic pressure increased with progression of hypertension.
Furthermore, under HS condition, F p (t ED ) increased by 93% from w16 to w20 after F b (t ED ) increased, which means that cardiac passive elasticity decreased after increase of F b (t ED ).
An application of the method to normal human hemodynamic model
We tried to x model parameters to complete the human hemodynamic simulation model that included unknown scale parameters. Since we need two scale parameter values to obtain all unknown scale parameter values, we rst sought to clarify the possible range for each parameter, and nally selected one set of parameter values in the range.
Hemodynamic model
The hemodynamic model we used was based on the infantile model proposed by Wang et al. [1] in 2012.
Circulation model
We used the original blood vessel model proposed by Heldt et al. [2] , since the model can reproduce physiological blood ow and distributions to the organs, and is stable under different simulation conditions, and the computation cost is quite low. The target was an adult human. Since our aim was to reproduce baseline hemodynamics, we removed the barore ex model and xed the cycle length at 1000 ms. To adjust the pre-and post-loading conditions to obtain the physiological pressure and volume ranges, we introduced two scale coef cients to the vascular resistance. K rp is a scale coef cient for the resistance of the vena [resistances of superior vena cava (R sup ), inferior vena cava (R inf ), and abdominal vena cava (R ab )], and K ra is for the resistance of the periphery [resistances of upper (R up1 ), splanchnic (R sp1 ), lower limbs (R ll ), and kidney (R kid )]. 
Cardiac cellular contraction model
NL08 model is one of the cardiac contraction models which can well reproduce the time course of the active contraction force under both isotonic and isometric conditions. Since NL08 model is known to have good reproducibility of the blood ow in the circulation model, we used the original NL08 model [4] for the cardiac cellular contraction model, except one modi cation. The NL08 model offers high contraction reproducibility, but has a problem in that the dissociation rate constants (g, g d ) for weak and strong attached cross-bridge states increase markedly when the cell length increases. This results in a rapid decrease in the contraction force during the lling phase. To improve the lling phase characteristics, we modi ed the formulation of γ by introducing the factor F γ .
Here, h w is the elongation of attached cross-bridges in a weak binding state, and h wr is its steady-state length. X w is non elastic portion of the contractile element. (15) and (16), which determines the positive non-linear cross-bridge detachment rate by the difference between h w and h wr that becomes greater if dL/dt becomes large. However, the contraction force becomes 0 after rapid elongation of L (Fig. 4 solid line) which does not happen in the real heart, since if this happens, the left ventricular pressure becomes negative at that moment. Thus we replaced γ by γ m in Eq. (15) and (16) which is identical to γ if the cell is contracting. However, by dividing γ by F γ , the value becomes small, which gives better force transient. By manually adjusting smoothness of the force time course, we used 85.3 as the value of F γ (Fig. 4 dashed line).
Calculation method for determining unknown model parameters
First, we selected a set of target hemodynamic parameters from the adult human physiological range (Table S2) . For EDPVR data at EDP2 and EDP3, we used the data reported by Perhonen et al. [25] . We used 77 mL as the target value for stroke volume (SV) [10] , and 60% for ejection fraction (EF) [34] .
Geens et al. [24] measured the left ventricular pressure-volume relationship in female sheep using a balloon catheter and MRI, and showed the relationship between EDPVR and V eq . From their data, V eq is 55 mL, and if we assume that P lv (t ED ) is 10 mmHg, V lv (t ED ) becomes 80 mL. We scaled these data to an adult human. If we use V lv (t ED ) of 128 mL [10, 34] , V eq becomes 88 mL. Perhonen et al. [25] also measured the left ventricle in healthy males using a balloon catheter and 2-dimensional echocardiography, and showed the standard physiological range for the equilibrium volume of 40 ∼ 90 mL. We used this range for the physiological adult human V eq .
Model parameter values in the model equation for left ventricular radius and volume (K α , K β , V γ ), as well as left ventricular radius and half sarcomere length (K L , L b ), were determined by scaling the canine experimental data to adult human standard physiological hemodynamic parameters shown in Table S2 . This resulted in the values shown in Table 2 .
F b (t ES ) and F b (t ED ) are calculated from the NL08 model in the hemodynamic model, but the actual cellular active contraction force in the working heart is not clear. Therefore, the scale parameter K S is necessary to relate cellular contraction force to wall tension in the current hemodynamic model. h lv (t ED2 ) and h lv (t ED3 ) are unknown, so we assumed that the differences among wall thickness at EDP, EDP2 and EDP3 are small; that is h lv (t ED ) ≈ h lv (t ED2 ) ≈ h lv (t ED3 ). We used the adult male range of wall thickness of 10-17 mm [35] .
The physiological range of the half sarcomere length is approximately 0.8-1.2 μm, and the cellular contraction force is maximal at around 1.1-1.15 μm [36]. However, the working range of the half sarcomere length is unclear. We assumed that the range is in the physiological range (0.95-1.10 μm).
From the above data, we rst set an initial L 0 value corresponding to V eq = 88 mL, which results in approximately 1.04 μm. The initial F b (t ED ) is also provided to calculate other scale parameter values. Using the calculated scale parameter values, the hemodynamic model is simulated to obtain steady-state. Since F b (t ED ) and K fb changes according to simulation conditions, steady-state values for F b (t ED ) and K fb are now used to recalculate other parameters, and the model is then simulated to obtain the steady-state using these values. These steps are repeated until the hemodynamic parameters reach the target values. The detailed step of the iterative calculation is explained in Supplement S2. Note that the proposed method calculates parameter values from the given F b (t ED ) and K fb , but their actual values are determined by the resulting numerical calculation of the differential equations of the NL08 model. Thus, if the given simulation condition can be realized by the model, then this iterative calculation gives converged result. However, if the model cannot reproduce the condition, the iterative calculation step never gives converged re- (36) sult.
Reproducing hemodynamics in steady-state
By performing the parameter calculation step described in the previous section, we nally obtained the scale parameter values shown in Table 3 (a). The resulting hemodynamic parameter values are shown in Table 4 (a). All hemodynamic parameter values were near the target value in the physiological range. The ejection fraction was 59.6%, which was within the physiological range of 49-82% [37] . By changing the preload scale factor K rp to achieve an end-diastolic pressure of 5.0-8.0 mmHg, we obtained several pressure and volume loops, as shown in Fig. 5 , which shows linear ESPVR. The maximal elastance (E max ) is 3.51, and is within the physiological range of 3.38-6.73 [38] . In Fig. 5(b) , the end-diastolic points show good agreement with the end-diastolic points reported by Perhonen et al. [25] (closed circles).
From these results, we can see that the proposed parameter calculation method provides unknown scale parameter values with which the physiological hemodynamic parameters can be realized in the simulation model.
Discussion and Limitations

Limitations
The proposed method is based on Laplace s law, thus the method can only be applied to the condition where no regional variation in heart wall exists. Due to this limitation, the method is dif cult to be applied to ischemic heart disease. The method also has limitation that it cannot handle the heart shape, or the phenomena arise from the heart shape.
Experimental hemodynamic parameters utilized in a
hypertensive rat model In section 4, since posterior wall thickness data was not reported in Klotz s paper [28] , we used the posterior wall thickness data at 12 weeks under HS reported by Qu et al. [33] , on the assumption that the wall thickness does not change from weeks 12 to 20. On the other hand, progression of septum wall thickness in hypertensive rats given LS or HS was reported in Klotz s paper. Here, we tried to evaluate the effect of the wall thickness change by referring to the septum wall thickness data. We used the septum wall thickness data reported by Klotz as the end-diastolic wall thickness, and calculated the end-systolic wall thickness using the data reported by Qu et al. (Table 5 ). Calculated K S ·F b (t ED ) and F p (t ED ) are shown in Fig. 6 . Figs. 3 and 6 , cases of constant wall thickness showed a larger increase in the HS condition, but the difference was small in the LS condition. K fb showed a small difference between constant and varying wall thickness cases. F p (t ED ) also showed a larger increase for the constant wall thickness, but the differences were not so large. We can therefore say that regardless of whether the wall thickness change is signi cant or not, the resulting K S ·F b (t ED ) and K fb changes are signi cant at some levels.
In section 4, the half sarcomere length at equilibrium volume L 0 was chosen from the physiological range, but the actual L 0 is not clear. Here, we evaluated the in uence of varying L 0 . Model parameters were calculated with L 0 multiplied by 0.95 and 1.03 Table 4 Simulated steady-state hemodynamic parameters in the normal human hemodynamic model. Table 6 ). Note that if we use L 0 multiplied by 1.05, some parameters have no solution from the calculation method. From the results, we can see that the passive elasticity-related parameters K PE and K PL are affected by L 0 change. However, the active force-related parameters K S ·F b (t ED ) and K fb respond minimally to an L 0 increase, but only K fb increases by 10% if L 0 increases by 3%. This can be understood by the force-length relation in cardiac cells.
In section 3, we made an assumption that the differences in h lv (t) at three end-diastolic points are small. V lv (t ED2 ) and V lv (t ED3 ) are 10-15% different from V lv (t ED ); thus we evaluated the effect of h lv proportional to V lv at end-diastole. The results showed that F p calculated from parameters K PE and K PL became large if we used h lv proportional to V lv , whereas other parameters had very small effect from this change. Thus we conclude that the results shown in section 4 are still valid under the assumption of constant end-diastolic h lv .
Evaluation of the validity of the assumptions used in the normal human hemodynamic model
In section 5, the working range of half sarcomere length was assumed as 0.95-1.10 μm, but no reports have clearly described this range. Here, we evaluated the effect of the half sarcomere length working range using the range of 1.05-1.20 μm, including the characteristics of the force-length relation of the NL08 model. Using the calculation method described in section 5, the parameter set shown in Table 3 (b) was obtained. Since some model parameters were calculated from the working range of half sarcomere length, the parameter values shown in Table S2, and Table 2 were modi ed. In Table S2 , ED3 ) were changed to 1.05, 1.20, 1.17, and 1.22. In Table 2 , L b was changed to 0.782.
The resulting steady-state hemodynamic parameters for the model are shown in Table 4 (b), and the ejection fraction was 59.6%, which was within the physiological range of 49-82% [37]. The measured E max was 2.84, and was smaller than the simulation results with half sarcomere length working range of 0.95-1.10 μm.
This E max reduction can be explained by the cellular forcelength relation characteristics. Since the maximal force-developing half sarcomere length is 1.15 μm, if the working range reaches this length, the variation in the end-systolic cellular force becomes small.
Conclusion
In this paper, we propose a novel method to determine unknown scale parameters in hemodynamic model composed of a cardiac cell model and a circulation model based on measured data from experimental hemodynamics. Using our method, we estimated the changes in scale parameters with progression of hypertension based on experimental data from hypertensive rats. The results clearly showed that both the end-diastolic contraction force and the ratio between the end-diastolic and the end-systolic contraction forces increase in the HS Dahl salt-sensitive rat. We also determined the unknown scale parameters for an adult human circulation model using data from physiological hemodynamics. Using our method, we successfully reproduced physiological hemodynamics in a simulation model.
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S1 Experimental data of hypertensive rats and normal humans
Hemodynamic parameters of hypertensive rats based on measured experimental data in hypertensive rats reported by Klotz et al [28] and Qu et al [33] are shown in Table S1 . Moreover, hemodynamic parameters of normal human adults based on measured experimental data in normal adults are shown in Table S2 .
S2 Iterative method to determine unknown parameters for use in a simulation model
In the proposed method, we have to provide values for two unknown parameters since there are seven unknown parameters and ve equations. If we use the determined parameter values for a 
hemodynamic simulation model, the results often do not satisfy the required ranges since the active contraction force will change according to the pressure and volume time courses. Here we explain the detail of how we determine the unknown parameter values by an iterative method. The method consists of seven steps as shown in Fig. S1 . There are two different methods to determine unknown parameters. In method 1, half sarcomere slack length (L 0 ) and end-diastolic cellular contraction force (F b (t ED )) are the known input parameters. In method 2, the ratio of end-systolic to end-diastolic cellular contraction force (K fb ) and end-diastolic active contraction force F b (t ED ) are the known input parameters.
Note that since the passive elastic force is considered to work as the lling force after end systole, V eq is presumed to be located between the end-diastolic volume (V lv (t ED )) and the end-systolic volume (V lv (t ES )) [23] . Thus one has to ensure that V eq is located between V lv (t ED ) and V lv (t ES ) [23] [24] [25] [26] . step 1 Provide two initial lengths for L 0 within the working range of half sarcomere length. We usually use 1.04 [μm] which corresponds to V eq = 88 [mL] as one candidate length, and another length close to this candidate. After the second iteration, values determined at step 5, and another length close to this length are used as two initial lengths. step 2 Using one initial length provided in step 1 and F b (t ED ), the other ve parameters are determined. The same process is repeated with another initial length provided in step 1 (method 1). For the rst iteration, use typical active force value within the normal range as F b (t ED ). After the second iteration, use simulation result as F b (t ED ). References: P lv [10, 25] ; V lv [10, 25, 34] ; h lv , R lv [35] ; L [17] . 
